文献速递脊柱关节炎其他结缔组织病

银屑病疾病中的恶性肿瘤:前瞻性纵向队列研究结果

Malignancy in psoriatic disease: Results from prospective longitudinal cohorts.
PubMed 文献 · Semin Arthritis Rheum · 2020-12-24

该研究基于1978年起前瞻性随访的PsA患者及2006年起随访的PsC患者队列,评估银屑病疾病(PsD)患者恶性肿瘤的患病率、发病率及预测因素。共纳入2051例PsD患者,228例(11%)发生癌症,其中168例在首次就诊后发生癌症并纳入分析。总体恶性肿瘤标准化发病比(SIR)为0.83(0.68, 1.00),女性SIR为1.06(0.80, 1.37),男性SIR为0.67(0.50, 0.88);皮肤癌是唯一发病率高于一般人群的特定癌症,SIR=3.37(1.84, 5.66)。

要点

  • PsD患者总体恶性肿瘤风险与一般人群相当,SIR为0.83(0.68, 1.00)。
  • 皮肤癌发病率显著高于一般人群,SIR=3.37(1.84, 5.66)。
  • 生物制剂使用与恶性肿瘤风险增加的证据不足。

核心结论

  • 在PsA和PsC患者的长期前瞻性随访中,总体恶性肿瘤风险未发现高于一般人群,但皮肤癌风险增加。

研究设计与样本

  • 纳入1978年起前瞻性随访的PsA患者和2006年起随访的PsC患者,按标准方案每6至12个月随访,前瞻性记录恶性肿瘤并通过链接Cancer Care Ontario和死亡登记处确认至2016年12月。
  • 共纳入2051例PsD患者,228例(11%)发生癌症,其中168例在首次就诊后发生癌症并纳入本报告。

主要发现

  • 总体恶性肿瘤SIR为0.83(0.68, 1.00),女性SIR为1.06(0.80, 1.37),男性SIR为0.67(0.50, 0.88)。
  • 最常见的恶性肿瘤为皮肤癌、乳腺癌和血液系统肿瘤。
  • 皮肤癌是唯一发病率高于一般人群的特定癌症,SIR=3.37(1.84, 5.66)。
  • 生物制剂使用与恶性肿瘤风险增加之间的证据不足。

临床怎么用

  • 对PsD患者应关注皮肤癌筛查,因其发病率高于一般人群。
  • 生物制剂使用与恶性肿瘤风险增加的证据不足,临床决策时可参考此结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To estimate the prevalence and incidence of malignancy and its types in psoriatic arthritis (PsA) and psoriasis without arthritis (PsC) patients, in comparison to the general population, and to identify the predictive factors for developing cancer in psoriatic disease (PsD). METHODS: PsA patients followed prospectively since 1978 and PsC patients followed since 2006 at 6-to-12 month intervals according to a standard protocol were included. Malignancies were recorded prospectively and linkages with Cancer Care Ontario and the Death Registry were carried out to confirm the presence and type of malignancy up to December 2016. Standardized incidence ratios (SIR) were calculated for overall cancers and by age and sex. Cox regression analysis was conducted to identify risk factors associated with the development of malignancy after the diagnosis of PsD. RESULTS: 2051 patients (PsD) were included of whom 228 (11%) developed cancer. 168 patients developed cancer after first clinic visit and are included in this report. Overall SIR for malignancy was 0.83 (0.68, 1.00), SIR for females was 1.06 (0.80, 1.37), and for males was 0.67 (0.50, 0.88). The most common malignancies were skin, breast, and hematological. Skin cancer was the only specific cancer that had a higher incidence than the general population with SIR = 3.37 (1.84, 5.66). There was insufficient evidence to suggest an increased risk of malignancy associated with biologics use. CONCLUSIONS: In this long-term prospective follow-up of patients with PsA and PsC the overall malignancy risk was not found to be higher than the general population, while skin cancer increased.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Polachek A, Muntyanu A, Lee KA, et al. Malignancy in psoriatic disease: Results from prospective longitudinal cohorts. Semin Arthritis Rheum. 2020. PMID: 33383290. doi:10.1016/j.semarthrit.2020.12.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。